Resources

In 2014, PATH conducted interviews with stakeholders in Senegal and Uganda to assess receptivity to self-injection of the contraceptive, subcutaneous DMPA (DMPA-SC, brand name Sayana Press) as well as the evidence requirements and processes necessary to chart a course for adoption, introduction, and scale-up of self-injection as a service-delivery practice in the two countries. For more information, email FPoptions@path.org or visit www.path.org/dmpa-sc.

This fact sheet highlights PATH’s work to address rotavirus, the leading cause of severe diarrheal disease. It includes general information about our efforts to increase access to and effectiveness of existing vaccines, as well as to develop new vaccines and to raise awareness through advocacy.

A report that describes the work that defined the first decade of the PATH Malaria Control and Elimination Partnership in Africa (MACEPA).

This study provides an analysis of the public budget and expenditure for research and development (R&D) in South Africa, with a specific focus on health R&D. It outlines the government’s research agenda and R&D funding trends across all departments, as well as funding and trends for health-specific R&D in the Departments of Health, Science and Technology, and Trade and Industry.

Hypoxemia has a high risk of mortality and requires treatment with lifesaving oxygen. However, oxygen is not always available or accessible, and many health facilities in low-resource settings are faced with insufficient supply. We seek to expand access to cost-effective, easy-to-use, and reliable oxygen technologies.